Diatreme Resources Limited (ASX:DRX)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Sep 14, 2026, 3:11 PM AEST
Diatreme Resources Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.08 | 0.14 | 0.39 | 0.46 | 0.11 | 0.02 |
Other Revenue | -0.53 | 0.04 | 0.5 | 0.01 | - | - |
| -0.45 | 0.19 | 0.89 | 0.47 | 0.11 | 0.02 | |
Revenue Growth | - | -79.09% | 89.21% | 325.38% | 360.09% | 12.50% |
Gross Profit | -0.45 | 0.19 | 0.89 | 0.47 | 0.11 | 0.02 |
Selling, General & Admin | 1.12 | 1.11 | 1.87 | 1.19 | 1.23 | 0.88 |
Other Operating Expenses | 2.18 | 1.81 | 3.25 | 1.93 | 1.55 | 0.87 |
Operating Expenses | 3.57 | 3.31 | 5.72 | 3.81 | 3.29 | 2.06 |
Operating Income | -4.01 | -3.12 | -4.83 | -3.34 | -3.18 | -2.04 |
Interest Expense | -0.1 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 |
Currency Exchange Gain (Loss) | 2.14 | 2.14 | - | - | - | - |
Other Non Operating Income (Expenses) | 0.36 | 0.33 | 0.24 | - | 0 | - |
EBT Excluding Unusual Items | -1.84 | -0.74 | -4.71 | -3.47 | -3.3 | -2.15 |
Gain (Loss) on Sale of Investments | -0.57 | -0.57 | - | 13.82 | 8.21 | - |
Gain (Loss) on Sale of Assets | -0.64 | 0.56 | 0.01 | 0.02 | 0.07 | - |
Other Unusual Items | - | - | 4.26 | - | - | - |
Pretax Income | -3.04 | -0.74 | -0.44 | 10.37 | 4.98 | -2.15 |
Net Income | -3.04 | -0.74 | -0.44 | 10.37 | 4.98 | -2.15 |
Net Income to Common | -3.04 | -0.74 | -0.44 | 10.37 | 4.98 | -2.15 |
Net Income Growth | - | - | - | 108.22% | - | - |
Shares Outstanding (Basic) | 3,890 | 5,008 | 4,303 | 3,730 | 3,368 | 2,705 |
Shares Outstanding (Diluted) | 3,890 | 5,008 | 4,303 | 3,732 | 3,368 | 2,705 |
Shares Change | -33.15% | 16.38% | 15.31% | 10.81% | 24.51% | 35.10% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
EPS Growth | - | - | - | 178.18% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.95 | -3.57 | -7.71 | -2.8 | -9.57 | -8.7 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | - | -1683.78% | -545.34% | -712.86% | -2889.61% | -8516.67% |
Profit Margin | - | -401.95% | -49.58% | 2212.61% | 4520.17% | -8979.73% |
Free Cash Flow Margin | - | -1923.68% | -869.29% | -598.26% | -8690.02% | -36340.14% |
EBITDA | -3.91 | -2.95 | -4.61 | -3.18 | -3.07 | -1.97 |
D&A For EBITDA | 0.1 | 0.17 | 0.22 | 0.16 | 0.11 | 0.07 |
EBIT | -4.01 | -3.12 | -4.83 | -3.34 | -3.18 | -2.04 |
Revenue as Reported | 2.57 | 3.21 | 5.39 | 14.3 | 8.39 | 0.02 |